AMRX
NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals Inc
$18.71
+0.43 (+2.35%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+87.10%
YTD
+47.79%
Open$18.12
Previous Close$18.28
Day High$18.81
Day Low$18.06
52W High$19.26
52W Low$9.49
Volume—
Avg Volume2.12M
Market Cap5.82B
P/E Ratio37.01
EPS$0.48
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.39
Above
SMA 200
$10.30
Above
RSI (14)
57.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+517.5% upside
Current
$18.71
$18.71
Target
$115.54
$115.54
$65.43
$115.54 avg
$156.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.89B | 2.61B | 607.96M |
| Net Income | 69.03M | 56.01M | 209.30M |
| Profit Margin | 2.4% | 2.3% | 34.4% |
| EBITDA | 591.90M | 506.94M | 317.16M |
| Free Cash Flow | — | — | 187.04M |
| Rev Growth | +10.9% | +10.9% | -4.4% |
| Debt/Equity | 136.58 | 136.58 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,152.93 | +0.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.99 | -0.09% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $146.87 | -0.19% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.66 | +0.07% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $63.06 | +0.35% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.40 | -2.22% | 11.5 | 30.15B |